Results 81 to 90 of about 9,833 (102)

Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry

Journal of Hepatology, 2021
Camilla Stephens, Mercedes Robles-Diaz, Inmaculada Medina-Caliz   +2 more
exaly  

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment

Metabolites, 2022
Marta Moreno-Torres, Guillermo QuintÁs, Jose V Castell   +2 more
exaly  

Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method

International Journal of Molecular Sciences, 2022
Rolf Teschke, Nahum Mendez-Sanchez
exaly  

Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review

Expert Opinion on Drug Metabolism and Toxicology, 2021
Edmond Atallah, Ismael Álvarez Álvarez, Francisco Javier Cubero   +2 more
exaly  

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes

Archives of Toxicology, 2021
Guillermo QuintÁs, Teresa Martinez-Sena, Jos Kleinjans   +2 more
exaly  

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice

Antioxidants, 2021
Marina Villanueva Paz, Cristiana Freixo, Raúl J Andrade   +2 more
exaly  

Clinical management of patients with drug‐induced liver injury (DILI)

United European Gastroenterology Journal, 2021
Einar S Björnsson
exaly  

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative

International Journal of Molecular Sciences, 2016
Fernando Bessone, Nelia Hernández, María Isabel Lucena González   +2 more
exaly